Details
Stereochemistry | ACHIRAL |
Molecular Formula | C27H48N6O9 |
Molecular Weight | 600.7048 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ON1CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC1=O
InChI
InChIKey=NHKCCADZVLTPPO-UHFFFAOYSA-N
InChI=1S/C27H48N6O9/c34-22-10-14-26(38)32(41)20-8-3-6-18-30-24(36)12-15-27(39)33(42)21-9-2-5-17-29-23(35)11-13-25(37)31(40)19-7-1-4-16-28-22/h40-42H,1-21H2,(H,28,34)(H,29,35)(H,30,36)
Nocardamine is a cyclic trihydroxamate. It belongs to a group of microbial siderophores which form complexes with iron and aluminum ions. Nocardamine was described first as an antibiotic active against mycobacteria and proteus. It is produced by Nocardia species, several Streptomyces species, Chromobacterium and Pseudomonas. Nocardamine exhibited significant antioxidant effects. It is suggested that it should be applied in food and biological model systems. In vitro nocardamine showed antitumor activity – it has inhibitory effects to colony formation of tumor cells.
Originator
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21376551
T-47D, SK-Mel-5, SK-Mel-28, RPMI-7951 cancer cells. The cells were treated with nocardamine at 5, 10, 20 and 40 uM in soft agar matrix and incubated at 37 ◦C in a 5% CO2 incubator for 3 weeks. Results indicated that nocardamine inhibited colony formation of T-47D, SK-Mel-5, SK-Mel-28, and RPMI-7951
cancer cells.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
50437
Created by
admin on Sat Dec 16 04:28:58 GMT 2023 , Edited by admin on Sat Dec 16 04:28:58 GMT 2023
|
PRIMARY | |||
|
m8022
Created by
admin on Sat Dec 16 04:28:58 GMT 2023 , Edited by admin on Sat Dec 16 04:28:58 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID00181161
Created by
admin on Sat Dec 16 04:28:58 GMT 2023 , Edited by admin on Sat Dec 16 04:28:58 GMT 2023
|
PRIMARY | |||
|
26605-16-3
Created by
admin on Sat Dec 16 04:28:58 GMT 2023 , Edited by admin on Sat Dec 16 04:28:58 GMT 2023
|
PRIMARY | |||
|
Q645668975
Created by
admin on Sat Dec 16 04:28:58 GMT 2023 , Edited by admin on Sat Dec 16 04:28:58 GMT 2023
|
PRIMARY | |||
|
161532
Created by
admin on Sat Dec 16 04:28:58 GMT 2023 , Edited by admin on Sat Dec 16 04:28:58 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD